Long-Term Mortality Associated with Periprosthetic Infection in Total Hip Arthroplasty
Journal of Bone and Joint Surgery · 16.07.2025 · 107 (14) · 1620-1627
DOI: 10.2106/jbjs.24.01629 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Bone and Joint Surgery, online erschienen am 03.06.2025. Verfasst von David G Campbell und 7 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Orthopaedic and Trauma Research, The University of Adelaide, Adelaide, Australia. Hauptthemen laut MEDLINE: Arthroplasty, Replacement, Hip, Prosthesis-Related Infections, Reoperation. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Abstract (Originalsprache)
Background
While the morbidity associated with revision total hip arthroplasty (THA) or periprosthetic infection (PJI) has been well characterized, less is known about the risk of mortality. With this study, we aimed to determine the long-term mortality associated with revision THA for PJI and associated risk factors.
Methods
Data from the Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR) were used to study mortality associated with THA procedures for osteoarthritis and subsequent revisions from September 1999 through December 2022. Kaplan-Meier estimates of survivorship and standardized mortality ratios (SMRs) based on Australian period life tables were used to summarize the overall survival following the primary and first revision THA. Risk factors associated with mortality were identified using Cox proportional hazards models, adjusted for age and gender.
Results
There were 548,061 primary THA procedures for osteoarthritis; 4,651 first revision procedures for infection and 15,891 first revisions for reasons other than infection and fracture were recorded. At 5, 10, and 15 years, the cumulative mortality rate for revision for PJI was 14.5%, 34.7%, and 57.5%, respectively. Patients who underwent revision for PJI had higher mortality rates than expected compared with the general population, and the corresponding SMR (1.31; 95% confidence interval [CI]: 1.24 to 1.39) was greater than that for patients undergoing primary THA (0.81; 95% CI: 0.81 to 0.82) or aseptic revision (0.95; 95% CI: 0.92 to 0.99). A higher SMR following revision for PJI was observed in patients
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Centre for Orthopaedic and Trauma Research, The University of Adelaide, Adelaide, Australia.
- Wakefield Orthopaedic Clinic, Adelaide, Australia.
- Infection Research Program, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia.
- Department of Surgery, Epworth Healthcare, University of Melbourne, Melbourne, Australia.
- South Australian Health and Medical Research Institute, Adelaide, Australia.
- Whitlam Orthopaedic Research Centre, Ingham Institute for Applied Medical Research, South West Sydney Clinical School, The University of New South Wales Sydney, Sydney, Australia.
ORCID-Profile: David G Campbell, Joshua S Davis, Michelle F Lorimer, Dylan Harries, Ian A Harris, Laurens Manning, Peter L Lewis
Zitieren
APA
Campbell, D. G., Davis, J. S., de Steiger, R. N., Lorimer, M. F., Harries, D., Harris, I. A., Manning, L., & Lewis, P. L. (2025). Long-Term Mortality Associated with Periprosthetic Infection in Total Hip Arthroplasty. Journal of Bone and Joint Surgery, 107(14), 1620-1627. https://doi.org/10.2106/jbjs.24.01629
Vancouver
Campbell DG, Davis JS, de Steiger RN, Lorimer MF, Harries D, Harris IA, et al. Long-Term Mortality Associated with Periprosthetic Infection in Total Hip Arthroplasty. Journal of Bone and Joint Surgery. 2025;107(14):1620-1627. doi:10.2106/jbjs.24.01629
BibTeX
@article{Campbell2025,
author = {Campbell, David G and Davis, Joshua S and de Steiger, Richard N and Lorimer, Michelle F and Harries, Dylan and Harris, Ian A and Manning, Laurens and Lewis, Peter L},
title = {Long-Term Mortality Associated with Periprosthetic Infection in Total Hip Arthroplasty},
journal = {Journal of Bone and Joint Surgery},
year = {2025},
volume = {107},
number = {14},
pages = {1620--1627},
doi = {10.2106/jbjs.24.01629}
}
EUVIMED